Ledger.Open graph →
SEC Form D · filed October 28, 2014

Alexza Pharmaceuticals Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MOUNTAIN VIEW, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Robert A. Lippe · Mountain View, CAExecDeepika R. Pakianathan · Mountain View, CADirectorThomas B. King · Mountain View, CAExec · DirectorGordon L. Ringold · Mountain View, CADirectorMark K. Oki · Mountain View, CAExecIsaac L. Stein · Mountain View, CADirectorJoseph L. Turner · Mountain View, CADirectorEdwin S. Kamemoto · Mountain View, CAExecJames V. Cassella · Mountain View, CAExecRakesh Gupta · Washington, Washington, D.C.ExecJ L. Read · Mountain View, CADirectorJ K. Buchi · Mountain View, CADirectorLew W. Jacobs Iv · NEWPORT BEACH, CADirectorBrent L. Holden · NEWPORT BEACH, CAExecSuhail H. Dada · NEWPORT BEACH, CAExecMihir P. Worah · NEWPORT BEACH, CAExec · DirectorScott A. Mather · NEWPORT BEACH, CADirectorBrent R. Harris · NEWPORT BEACH, CAExecDouglas M. Hodge · NEWPORT BEACH, CADirectorRavinder K. Mattu · NEWPORT BEACH, CADirectorAnita Gupta · Washington, Washington, D.C.ExecJ L. Read · Mountain View, CADirectorJ K. Buchi · Mountain View, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗